17-7307083-C-T

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 3P and 8B. PM1PP2BP4_StrongBS2

The ENST00000336452.11(EIF5A):​c.37C>T​(p.Arg13Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000904 in 1,603,524 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R13S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00054 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000043 ( 0 hom. )

Consequence

EIF5A
ENST00000336452.11 missense

Scores

2
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.158
Variant links:
Genes affected
EIF5A (HGNC:3300): (eukaryotic translation initiation factor 5A) Enables U6 snRNA binding activity and protein N-terminus binding activity. Involved in several processes, including cellular response to virus; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator; and tumor necrosis factor-mediated signaling pathway. Located in annulate lamellae; cytoplasm; and nucleus. Part of nuclear pore. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

PM1
In a chain Eukaryotic translation initiation factor 5A-1 (size 152) in uniprot entity IF5A1_HUMAN there are 16 pathogenic changes around while only 1 benign (94%) in ENST00000336452.11
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), EIF5A. . Gene score misZ 2.407 (greater than the threshold 3.09). Trascript score misZ 3.6907 (greater than threshold 3.09). GenCC has associacion of gene with Faundes-Banka syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.008883923).
BS2
High AC in GnomAd4 at 82 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
EIF5ANM_001143760.1 linkuse as main transcriptc.37C>T p.Arg13Cys missense_variant 1/6 NP_001137232.1
EIF5ANM_001370420.1 linkuse as main transcriptc.-52C>T 5_prime_UTR_variant 1/6 NP_001357349.1
EIF5AXM_017024301.3 linkuse as main transcriptc.-59C>T 5_prime_UTR_variant 1/2 XP_016879790.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
EIF5AENST00000336452.11 linkuse as main transcriptc.37C>T p.Arg13Cys missense_variant 1/61 ENSP00000336702 P63241-2

Frequencies

GnomAD3 genomes
AF:
0.000545
AC:
83
AN:
152226
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00162
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000955
GnomAD3 exomes
AF:
0.0000889
AC:
21
AN:
236214
Hom.:
0
AF XY:
0.0000701
AC XY:
9
AN XY:
128394
show subpopulations
Gnomad AFR exome
AF:
0.00104
Gnomad AMR exome
AF:
0.000125
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000354
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000928
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000434
AC:
63
AN:
1451180
Hom.:
0
Cov.:
30
AF XY:
0.0000264
AC XY:
19
AN XY:
720994
show subpopulations
Gnomad4 AFR exome
AF:
0.00135
Gnomad4 AMR exome
AF:
0.000115
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000120
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.03e-7
Gnomad4 OTH exome
AF:
0.000183
GnomAD4 genome
AF:
0.000538
AC:
82
AN:
152344
Hom.:
1
Cov.:
32
AF XY:
0.000456
AC XY:
34
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.00159
Gnomad4 AMR
AF:
0.000915
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000945
Alfa
AF:
0.0000681
Hom.:
0
Bravo
AF:
0.000623
ExAC
AF:
0.0000997
AC:
12

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 05, 2021The c.37C>T (p.R13C) alteration is located in exon 1 (coding exon 1) of the EIF5A gene. This alteration results from a C to T substitution at nucleotide position 37, causing the arginine (R) at amino acid position 13 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
12
DANN
Benign
0.97
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.018
N
LIST_S2
Benign
0.48
T
M_CAP
Benign
0.0094
T
MetaRNN
Benign
0.0089
T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.42
N
REVEL
Benign
0.024
Sift
Uncertain
0.015
D
Sift4G
Uncertain
0.046
D
Polyphen
0.13
B
Vest4
0.20
MutPred
0.16
Loss of MoRF binding (P = 0.0047);
MVP
0.21
MPC
0.0017
ClinPred
0.030
T
GERP RS
0.67
gMVP
0.38

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs575429378; hg19: chr17-7210402; API